Veritas Capital related stories
All articles and analysis
Where’s the ROI in AI?In theory, artificial intelligence should slash costs and ramp up productivity at the GP level, but achieving a return on that investment is proving to be a slow process.
Seven deals signal PE’s rising appetite for patient engagement platformsPrivate equity is zeroing in on healthtech investments that focus on technology-driven patient support.
Meet the LP: LatAm's Axxets ManagementThe Latin American multifamily office has a near-term target of at least one-fifth of its clients’ holdings being placed in alternatives, says Daniel Sanchez, head of alts.
Longer hold periods stretch GPs’ plansLPs have started raising concerns about their GPs’ value creation plans for those portfolio companies sitting within older funds, writes Giovanni Legorano. So, are long-held assets receiving enough TLC?
Tech specialist Veritas seeks at least $13bn for latest flagshipThe firm’s 2016-vintage Fund VI was producing a 2.03x DPI as of December 2023, according to PEI Group data.
Cathay Life commits $60m to Veritas buyout fundTaiwan-based insurance company backs Veritas Capital's ninth flagship buyout fund.
Fubon Life backs Veritas fund with $70m commitmentTaiwan-based insurance company backs a private equity fund that focuses on North American buyouts.
Veritas held a final close on its eighth flagship fundVeritas has raised $10.65bn.
Side Letter: Ardian's key person shake-up; PAG's IPO titbits; PE's fundraising 'indigestion'The key person team investing Ardian's next secondaries mega-fund is going to look very different from its 2020-vintage predecessor. Plus: Extras from PAG's Hong Kong IPO filing and why TPG believes LPs are suffering from 'fundraising indigestion'. Here's today's brief, for our valued subscribers only.
Side Letter: Spanish PE reign, Manulife's Houlihan hires, PEI Awards 2019Finding all this Brexit-related drama exhausting? Read our latest on Spain's PE industry below where deal volume is set to hit a record and the industry's future is bright. Here’s today's brief, for our valued subscribers only.